Ndt Pharmaceuticals(OTC) MILV

Market CapN/A

Since IPO (2011)-99%

5 Year-60%

1 Year+321%

1 Month-28%

N/A

Ndt Pharmaceuticals last closing stock price
Metric	Price	Date
Last close	USD 0.40	2026-08-31

Ndt Pharmaceuticals stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-22.86%	USD 0.51	2026-08-24
1 month	-28.01%	USD 0.55	2026-07-31
3 month	-32.53%	USD 0.59	2026-06-02
Year to date	-77.88%	USD 1.79	2025-12-31
1 year	+321.23%	USD 0.09	2025-08-29
3 year	-56%	USD 0.90	2023-09-01
5 year	-60.4%	USD 1.00	2021-08-31
Since inception	-99.39%	USD 65.00	2011-10-21

Ndt Pharmaceuticals Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.28

Net Income (TTM)

-$1.02

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

MILV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ndt Pharmaceuticals

NDT Pharmaceuticals, Inc. is a development stage company. It seeks for opportunities in vitamin and supplement industry. The company was founded on May 13, 2005 and is headquartered in Vienna, VA.

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Joseph C. Passalaqua

Website

www.ndtpharma.com

MILV Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

N/A

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Payout Ratio

N/A

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Ndt Pharmaceuticals Performance Analysis

Ndt Pharmaceuticals annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2023	2023-12-31	USD 0	N/A
2024	2024-12-31	USD 0	N/A
2025	2025-12-31	USD 0	N/A

Ndt Pharmaceuticals annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2023	2023-12-31	USD -0.00	N/A
2024	2024-12-31	USD -0.00	-80.0%
2025	2025-12-31	USD -0.00	100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.16

N/A

Gross Profit

-$0.36

N/A

Gross Margin

-233.28%

N/A

Market Cap

N/A

Market Cap/Employee

$5.65

N/A

Employees

N/A

Net Income

-$0.72

+239.0%

EBITDA

-$0.33

+109.1%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$0.78

+120742.7%

Total Debt

$0.70

N/A

Accounts Receivable

$0.54

N/A

Inventory

$1.69

N/A

Long Term Debt

$0.70

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-5.09%

+0.7%

Return on Invested Capital

-49.11%

+1.0%

Free Cash Flow

-$0.47

+44.8%

Operating Cash Flow

-$0.47

+44.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,634.27-0.01%

^DJIDJI

^DJIDJI$52,797.46-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,099.39-0.01%

BTCBitcoin

BTCBitcoin$77,103.00-0.02%

SPCXSPCX

SPCXSPCX$143.28-0.00%

AAPLAAPL

AAPLAAPL$324.80+0.03%

AMZNAMZN

AMZNAMZN$255.17-0.02%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$14.06+0.06%

NVDANvidia

NVDANvidia$217.44-0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.33-0.06%

INTCIntel

INTCIntel$88.97-0.01%

ONDSOndas

ONDSOndas$7.04-0.08%

NUNu Holdings

NUNu Holdings$14.46-0.01%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.38-0.02%

Questions About MILV

What is the current price of Ndt Pharmaceuticals?

Ndt Pharmaceuticals is trading at N/A per share.

What is the 52-week range for Ndt Pharmaceuticals?

Over the past 52 weeks, Ndt Pharmaceuticals has traded between N/A and N/A.

How much debt does Ndt Pharmaceuticals have?

As of the most recent reporting period, Ndt Pharmaceuticals reported total debt of $701.00K.

How much cash does Ndt Pharmaceuticals have on hand?

Ndt Pharmaceuticals reported $80.85K in cash and cash equivalents in its most recent financial results.

What is Ndt Pharmaceuticals’s dividend yield?

Ndt Pharmaceuticals does not currently have a dividend yield.

Ndt Pharmaceuticals(OTC) MILV

Ndt Pharmaceuticals Financials at a Glance

MILV News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ndt Pharmaceuticals

MILV Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ndt Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MILV

What is the current price of Ndt Pharmaceuticals?

What is the 52-week range for Ndt Pharmaceuticals?

How much debt does Ndt Pharmaceuticals have?

How much cash does Ndt Pharmaceuticals have on hand?

What is Ndt Pharmaceuticals’s dividend yield?

Premium Investing Services